GSK Biologicals
Showing 1 - 25 of 887
Gastroenteritis Trial in China (GSK's liquid oral live attenuated HRV, PCV-free liquid formulation of GSK's oral live attenuated
Recruiting
- Gastroenteritis
- GSK's liquid oral live attenuated HRV
- PCV-free liquid formulation of GSK's oral live attenuated HRV
-
Chengdu, Sichuan, China
- +7 more
Sep 7, 2023
Malaria Trial in Kumasi, Kisumu (RTS,S/AS01E (Full dose), RTS,S/AS01E (1/5th dose), Rabies vaccine)
Completed
- Malaria
- RTS,S/AS01E (Full dose)
- +2 more
-
Kumasi, Ghana
- +1 more
Jan 24, 2023
Virus Diseases Trial in Hradec Kralove (Encepur Adults)
Completed
- Virus Diseases
- Encepur Adults
-
Hradec Kralove, CzechiaGSK Investigational Site
Jul 4, 2022
GSK's Phase IIb Malaria Vaccine Trial Entitled "Efficacy, Safety
Active, not recruiting
- Malaria
-
Kumasi, Ghana
- +1 more
Jun 23, 2022
Herpes Zoster Trial in Worldwide (HZ/su vaccine GSK1437173A, Prevenar13)
Completed
- Herpes Zoster
- HZ/su vaccine GSK1437173A
- Prevenar13
-
Marlborough, Massachusetts
- +12 more
Dec 23, 2021
Malaria, Malaria Vaccines Trial in Kintampo, Kumasi (Vitamin A, Candidate Plasmodium falciparum malaria vaccine, MR-Vac)
Completed
- Malaria
- Malaria Vaccines
- Vitamin A
- +3 more
-
Kintampo, Ghana
- +1 more
Sep 7, 2021
Influenza Trial in Canada, Dominican Republic, Honduras (Quadrivalent influenza GSK2282512A vaccine, Fluarix)
Completed
- Influenza
- Quadrivalent influenza GSK2282512A vaccine
- Fluarix
-
Halifax, Nova Scotia, Canada
- +7 more
Oct 19, 2021
Herpes Zoster Trial in Worldwide (Herpes Zoster subunit (HZ/su) vaccine (GSK1437173A), Placebo)
Active, not recruiting
- Herpes Zoster
- Herpes Zoster subunit (HZ/su) vaccine (GSK1437173A)
- Placebo
-
Tallinn, Estonia
- +43 more
Nov 14, 2022
Hepatitis B, Chronic Trial in Worldwide (ChAd155-hIi-HBV low dose formulation, ChAd155-hIi-HBV high dose formulation,
Recruiting
- Hepatitis B, Chronic
- ChAd155-hIi-HBV low dose formulation
- +6 more
-
Antwerpen, Belgium
- +35 more
Jan 28, 2022
COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)
Not yet recruiting
- COVID-19
- mRNA-CR-04 vaccine 10μg
- +3 more
-
San Diego, California
- +3 more
Aug 1, 2023
Infections, Streptococcal, Streptococcus Pneumoniae Trial in Helsinki (Pneumococcal conjugate vaccine GSK1024850A, GSK
Completed
- Infections, Streptococcal
- Streptococcus Pneumoniae
- Pneumococcal conjugate vaccine GSK1024850A
- +2 more
-
Helsinki, FinlandGSK Investigational Site
Nov 20, 2020
Infections, Streptococcal Trial in Germany (Pneumococcal vaccine GSK2830930A, Synflorix™)
Completed
- Infections, Streptococcal
- Pneumococcal vaccine GSK2830930A
- Synflorix™
-
Kehl, Baden-Wuerttemberg, Germany
- +3 more
Feb 8, 2021
Herpes Zoster, Herpes Zoster Vaccine Trial in Belgium, Canada, United States (Herpes Zoster vaccine (GSK 1437173A))
Completed
- Herpes Zoster
- Herpes Zoster Vaccine
- Herpes Zoster vaccine (GSK 1437173A)
-
Mesa, Arizona
- +7 more
Apr 19, 2021
Herpes Zoster, Herpes Zoster Vaccine Trial in Canada, Estonia, United States (Herpes Zoster vaccine GSK 1437173A, Licensed
Completed
- Herpes Zoster
- Herpes Zoster Vaccine
- Herpes Zoster vaccine GSK 1437173A
- Licensed pneumococcal polysaccharide conjugate vaccine (23-valent, adsorbed), Pneumovax 23™
-
Golden, Colorado
- +8 more
Apr 19, 2021
Respiratory Syncytial Virus Infections Trial in Worldwide (RSV (GSK3389245A) low dose formulation vaccine, RSV (GSK3389245A)
Completed
- Respiratory Syncytial Virus Infections
- RSV (GSK3389245A) low dose formulation vaccine
- +3 more
-
Anaheim, California
- +23 more
Sep 28, 2021
Respiratory Disorders Trial in Gent, Leuven, Wilrijk (Blood sampling, GSK biologicals investigational NTHi Mcat vaccine
Completed
- Respiratory Disorders
- Blood sampling
- +3 more
-
Gent, Belgium
- +2 more
Mar 12, 2021
Pneumococcal Vaccine on Nasopharyngeal Carriage
Completed
- Pneumococcal Infections
- PCV GSK1024850A
- hepatitis B vaccine or hepatitis A vaccine
-
Tampere, FinlandNational Institute for Health and Welfare
Feb 3, 2021
Influenza, Human Trial in Belgium, United States (D-SUIV cH8/1N1+AS03, D-SUIV cH5/1N1+AS03, D-SUIV cH11/1N1+AS03)
Completed
- Influenza, Human
- D-SUIV cH8/1N1+AS03
- +10 more
-
South Miami, Florida
- +5 more
Apr 14, 2021
Infections, Streptococcal, Streptococcus Pneumoniae Trial in Finland (Pneumococcal conjugate vaccine Synflorix (GSK1024850A),
Completed
- Infections, Streptococcal
- Streptococcus Pneumoniae
- Pneumococcal conjugate vaccine Synflorix (GSK1024850A)
- +2 more
-
Espoo, Finland
- +14 more
Nov 20, 2020
Respiratory Syncytial Virus Infections Trial in Worldwide (RSV MAT 60 µg, RSV MAT 120 µg, Placebo)
Completed
- Respiratory Syncytial Virus Infections
- RSV MAT 60 µg
- +2 more
-
Phoenix, Arizona
- +31 more
Nov 12, 2021
Influenza Trial in Worldwide (GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations), GSK Biologicals'
Completed
- Influenza
- GSK Biologicals' investigational vaccine GSK2340274A (alternative formulations)
- +2 more
-
Kippa Ring, Queensland, Australia
- +16 more
Feb 3, 2021
Cervical Intraepithelial Neoplasia Trial in China (HPV (Types 16, 18) Vaccine, Adsorbed)
Completed
- Cervical Intraepithelial Neoplasia
- HPV (Types 16, 18) Vaccine, Adsorbed
-
Jintan, Jiangsu, China
- +3 more
Nov 23, 2020
Human Papillomavirus (HPV) Infection Trial in Dakar, Mwanza (Cervarix, Placebo Al(OH)3)
Completed
- Human Papillomavirus (HPV) Infection
- Cervarix
- Placebo Al(OH)3
-
Dakar, Senegal
- +1 more
Oct 26, 2020
Infections, Meningococcal Trial in Puerto Rico, United States (Bexsero (GSK Biologicals' Meningococcal group-B vaccine/
Recruiting
- Infections, Meningococcal
- Bexsero (GSK Biologicals' Meningococcal group-B vaccine/ rMenB+OMV NZ)
- +7 more
-
Birmingham, Alabama
- +57 more
Jun 26, 2022